Literature DB >> 518674

Human thymidylate synthetase--III. Effects of methotrexate and folate analogs.

D W Szeto, Y C Cheng, A Rosowsky, C S Yu, E J Modest, J R Piper, C Temple, R D Elliott, J D Rose, J A Montgomery.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 518674     DOI： 10.1016/0006-2952(79)90039-x

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN： 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  13 in total

Review 1.  Polyglutamation of methotrexate. Is methotrexate a prodrug?

Authors:  B A Chabner; C J Allegra; G A Curt; N J Clendeninn; J Baram; S Koizumi; J C Drake; J Jolivet
Journal:  J Clin Invest       Date:  1985-09       Impact factor: 14.808

Review 2.  Will pharmacogenetics allow better prediction of methotrexate toxicity and efficacy in patients with rheumatoid arthritis?

Authors:  P Ranganathan; S Eisen; W M Yokoyama; H L McLeod
Journal:  Ann Rheum Dis       Date:  2003-01       Impact factor: 19.103

Review 3.  Clinical pharmacokinetics of methotrexate in children.

Authors:  Y M Wang; T Fujimoto
Journal:  Clin Pharmacokinet       Date:  1984 Jul-Aug       Impact factor: 6.447

Review 4.  Pharmacogenetics: implications for therapy in rheumatic diseases.

Authors:  Lesley Davila; Prabha Ranganathan
Journal:  Nat Rev Rheumatol       Date:  2011-08-09       Impact factor: 20.543

5.  Pharmacologic studies on the dibutyl and gamma-monobutyl esters of methotrexate in the rhesus monkey.

Authors:  A Rosowsky; H T Abelson; G P Beardsley; W D Ensminger; D W Kufe; G Steele; E J Modest
Journal:  Cancer Chemother Pharmacol       Date:  1982-12       Impact factor: 3.333

6.  Intracellular pharmacokinetics of methotrexate polyglutamates in human breast cancer cells. Selective retention and less dissociable binding of 4-NH2-10-CH3-pteroylglutamate4 and 4-NH2-10-CH3-pteroylglutamate5 to dihydrofolate reductase.

Authors:  J Jolivet; B A Chabner
Journal:  J Clin Invest       Date:  1983-09       Impact factor: 14.808

7.  Determinants of the sensitivity of human small-cell lung cancer cell lines to methotrexate.

Authors:  G A Curt; J Jolivet; D N Carney; B D Bailey; J C Drake; N J Clendeninn; B A Chabner
Journal:  J Clin Invest       Date:  1985-10       Impact factor: 14.808

Review 8.  Pharmacogenetics of methotrexate in acute lymphoblastic leukaemia: why still at the bench level?

Authors:  Sunitha Kodidela; Pradhan Suresh Chandra; Biswajit Dubashi
Journal:  Eur J Clin Pharmacol       Date:  2013-12-27       Impact factor: 2.953

Review 9.  Old drugs, old problems: where do we stand in prediction of rheumatoid arthritis responsiveness to methotrexate and other synthetic DMARDs?

Authors:  Vasco Crispim Romão; Helena Canhão; João Eurico Fonseca
Journal:  BMC Med       Date:  2013-01-23       Impact factor: 8.775

10.  Impact of genetic polymorphisms on chemotherapy toxicity in childhood acute lymphoblastic leukemia.

Authors:  Guillermo Gervasini; Jose M Vagace
Journal:  Front Genet       Date:  2012-11-22       Impact factor: 4.599
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.